News

Lipid kinases are enzymes that play a critical role in both cell signaling and membrane trafficking by phosphorylating lipid ...
Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose ...
Data from three terminally ill cardiogenic shock patients showcase potential of procizumab to safely reverse shock within 48 hours and p ...
Research on γ-secretase reveals its unique substrate recognition mechanism, offering potential for developing precise ...
Improving antimicrobial stewardship through novel anti-infectives is the need of the hour: Dr Surendran: Shardul Nautiyal, Mumbai Tuesday, July 15, 2025, 08:00 Hrs [IST] Improving ...
A new Yale study has found a promising target for treating the brain fog that can follow COVID-19 and offers new insight into ...
To pick the best pineapple in the market, you need to smell it, squeeze it, tug at the leaves, check its weightiness, and ...
Protein gives you energy thanks to amino acids. Learn why researchers want to reassess daily protein recommendations and what ...
A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune response against cancer.
Lipid kinases are enzymes that play a critical role in both cell signalling and membrane trafficking by phosphorylating lipid ...
This discovery not only unveils a novel mechanism by which BAT influences liver metabolism but also highlights miR-206-3p as a potential therapeutic ...
Baxdrostat is an investigational highly selective, oral, small molecule designed to inhibit aldosterone synthase.